ImmunityBio and NantKwest Complete Merger

Creates Leading Immunotherapy and Cell Therapy Company CULVER CITY & EL SEGUNDO, Calif., March 9, 2021 — ImmunityBio, Inc. and NantKwest, Inc. (NASDAQ: NK), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the...